ArticleCurrent oncology (Toronto, Ont.)2025
Examining a Genomic Test in Predicting Extended Endocrine Benefit and Recurrence Risk in a Diverse Breast Cancer Population.
Ho Hyun Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.